A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies

NCT00726882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV Infection

Interventions

PROCEDURE: Blood sample collection only
DRUG: ABT-333

Sponsor

AbbVie (prior sponsor, Abbott)